Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neelu Kaila

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|August 20, 2010
Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injuryAdrian Huang, Alessandro Moretto, Kristin Janz, et al.
Bioorganic & Medicinal Chemistry|August 1, 2007
Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3-carbonitrilesNeelu Kaila, Neal Green, Huan-Qiu Li, et al.
Journal of Medicinal Chemistry|August 27, 2025
Knowledge and Structure-Based Drug Design of 15-PGDH InhibitorsLeela S Dodda, Sebastien Campos, David Ciccone, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2007
Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosisPatricia W Bedard, Valerie Clerin, Natalia Sushkova, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2021
Structural basis for isoform-specific inhibition of human CTPS1Eric M Lynch, Michael A DiMattia, Steven Albanese, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole bloodJunjun Wu, Neal Green, Rajeev Hotchandani, et al.
Frontiers in Medicine|August 15, 2022
Human Recombinant Alkaline Phosphatase (Ilofotase Alfa) Protects Against Kidney Ischemia-Reperfusion Injury in Mice and Rats Through Adenosine ReceptorsDiane L Rosin, J Perry Hall, Shuqiu Zheng, et al.
Thrombosis and Haemostasis|March 6, 2007
Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulationDaniel D Myers, Shirley K Wrobleski, Chris Longo, et al.
Journal of Medicinal Chemistry|August 25, 2007
Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitrilesNeal Green, Yonghan Hu, Kristin Janz, et al.
Journal of Medicinal Chemistry|June 25, 2005
Quinic acid derivatives as sialyl Lewis(x)-mimicking selectin inhibitors: design, synthesis, and crystal structure in complex with E-selectinNeelu Kaila, William S Somers, Bert E Thomas, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|August 20, 2010
Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injuryAdrian Huang, Alessandro Moretto, Kristin Janz, et al.
Bioorganic & Medicinal Chemistry|August 1, 2007
Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3-carbonitrilesNeelu Kaila, Neal Green, Huan-Qiu Li, et al.
Journal of Medicinal Chemistry|August 27, 2025
Knowledge and Structure-Based Drug Design of 15-PGDH InhibitorsLeela S Dodda, Sebastien Campos, David Ciccone, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2007
Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosisPatricia W Bedard, Valerie Clerin, Natalia Sushkova, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2021
Structural basis for isoform-specific inhibition of human CTPS1Eric M Lynch, Michael A DiMattia, Steven Albanese, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole bloodJunjun Wu, Neal Green, Rajeev Hotchandani, et al.
Frontiers in Medicine|August 15, 2022
Human Recombinant Alkaline Phosphatase (Ilofotase Alfa) Protects Against Kidney Ischemia-Reperfusion Injury in Mice and Rats Through Adenosine ReceptorsDiane L Rosin, J Perry Hall, Shuqiu Zheng, et al.
Thrombosis and Haemostasis|March 6, 2007
Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulationDaniel D Myers, Shirley K Wrobleski, Chris Longo, et al.
Journal of Medicinal Chemistry|August 25, 2007
Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitrilesNeal Green, Yonghan Hu, Kristin Janz, et al.
Journal of Medicinal Chemistry|June 25, 2005
Quinic acid derivatives as sialyl Lewis(x)-mimicking selectin inhibitors: design, synthesis, and crystal structure in complex with E-selectinNeelu Kaila, William S Somers, Bert E Thomas, et al.
Pageof 4